Clinical Trials
- Diabetes
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
- Ages10 years - 17 years
- GenderBoth
- Heart/Cardiovascular
Ertugliflozin in Acute Heart Failure
- Ages18 years and older
- GenderBoth
- Children's Health, Diabetes, Endocrine System
Pathway to Prevention Study
- Ages1 year - 45 years
- GenderBoth
- Kidney & Urinary Tract
The Impact of Phosphate Metabolism on Healthy Aging
- Ages13 years and older
- GenderBoth
- Children's Health, Diabetes
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System
- Ages7 years - 75 years
- GenderBoth
- Diabetes
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer) A Proof-of-Concept Study
- Ages7 years - 17 years
- GenderBoth
- Heart/Cardiovascular
TARGET BP I Clinical Trial (TARGET BP I)
- Ages18 years - 80 years
- GenderBoth
- Diabetes
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22)
- Ages3 years and older
- GenderBoth
- Pregnancy and Obstetrics, Heart/Cardiovascular
Chronic Hypertension and Pregnancy (CHAP) Project (CHAP)
- Ages12 years and older
- GenderFemale only
- Heart/Cardiovascular
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3